Trial site
Athens
- 11running trials
- 9closed trials
The trials here
What the 20 trials at this site are about, from their registry records.
- Conditions
- Chronic myeloid leukaemia5 trials
- Familial hypercholesterolaemia4 trials
- Multiple sclerosis4 trials
- Coronary artery disease3 trials
- Stroke3 trials
- Childhood cancers2 trials
- Acute myeloid leukaemia1 trial
- Aortic stenosis1 trial
- Heart failure1 trial
- High blood pressure1 trial
- Lung cancer1 trial
- Melanoma1 trial
- and 5 more
- Phase
- Phase 312 trials
- Phase 23 trials
- Phase 1/22 trials
- Phase 41 trial
- Status
- Completed8 trials
- Active, not recruiting7 trials
- Recruiting4 trials
- Terminated1 trial
- Lead sponsor
- Novartis Pharmaceuticals20 trials
Running trials
Active, not recruiting
Recruiting
Recruiting
Kesimpta (Ofatumumab) in Greek Multiple Sclerosis Patients - an Observational Study
Recruiting
Recruiting
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Multiple sclerosis2 recruiting
- Aortic stenosis1 recruiting
- Familial hypercholesterolaemia1 recruiting
- Heart failure1 recruiting
- High blood pressure1 recruiting
- Pulmonary arterial hypertension1 recruiting
Closed trials
Recruiting
Completed
Completed
Study of Safety and Tolerability of CFZ533 in Patients With Sjögren's Syndrome
Completed
Terminated
Completed
Completed
Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients
Completed
Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop)
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026